Varsity Healthcare Partners Completes Sale of Probo Medical

Varsity Healthcare Partners (“VHP”), a leading healthcare services private equity investment firm, announced today the close of its sale of Probo Medical, LLC (“Probo” or “the Company”) to Avista Capital Partners (“Avista”). Terms of the transaction were not disclosed.

VHP initially invested in Probo in September 2018, at which point Probo was focused exclusively on the U.S. ultrasound repair and resale market. Since that time, the VHP and Probo partnership has worked collaboratively to both grow and diversify the Company’s service lines, leveraging an organic and targeted acquisition strategy to expand Probo’s recurring service capabilities globally.

Today, Probo offers a vertically integrated set of medical imaging products and services to customers worldwide, including equipment sales, part sales, equipment rentals, depot repair service, equipment installation and de-installation, and contractual field-based repair service.

The Company also now provides its full suite of services across a spectrum of imaging modalities, including Ultrasound, PET, X-Ray, C-Arms, CT Scanners, MRI, and Mammography machines.

Probo’s footprint includes fourteen facilities across the United States, the United Kingdom, Germany, France, and Canada, breaking into international markets as demand continues to grow for refurbished imaging equipment and service solutions that extend machinery lifespan.

Cain Brothers, a division of KeyBanc Capital Markets, acted as lead financial advisor, Houlihan Lokey acted as co-financial advisor, and Morgan Lewis acted as legal advisor to Varsity Healthcare Partners. Ropes & Gray acted as legal advisor to Avista Capital Partners.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.